Phase II Trial of Docetaxal Plus Imatinib Mesylate in the Treatment of Patients With Metastatic Breast Cancer

Title
Phase II Trial of Docetaxal Plus Imatinib Mesylate in the Treatment of Patients With Metastatic Breast Cancer
Authors
Keywords
-
Journal
Clinical Breast Cancer
Volume 9, Issue 4, Pages 237-242
Publisher
Elsevier BV
Online
2009-12-24
DOI
10.3816/cbc.2009.n.040

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started